Position in ANVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$37,200
-$7,400 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 61 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthspire Advisors, LLC holds $11,785,631 across 19 Biotechnology names. ANVS ranks #14 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,042 | $4,390,968 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
721,788 | $3,349,096 | |
| 3 | OCUL |
Ocular Therapeutix, Inc
|
162,960 | $1,600,267 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,138 | $565,278 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
3,540 | $307,803 | |
| 6 | MRNA |
Moderna, Inc.
|
3,953 | $276,828 | |
| 7 | RNXT |
RenovoRx, Inc.
|
252,525 | $247,474 | |
| 8 | MREO |
Mereo BioPharma Group plc
|
765,000 | $243,270 |
All Filings in ANVS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,200 | 20,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $44,600 | 20,000 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $69,200 | 20,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,700 | 10,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,700 | 10,000 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $15,075 | 10,050 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $50,551 | 10,050 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $80,600 | 10,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $57,600 | 10,000 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $119,000 | 10,000 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $205,513 | 10,990 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $94,900 | 10,000 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $142,900 | 10,000 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $154,100 | 10,000 | Shares | Sole | 2023-05-09 | |
| 2021-09-30 | $238,125 | 7,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $427,900 | 5,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $279,000 | 10,000 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||